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Background: Upper gastrointestinal bleeding (UGIB) remains a common medical problem worldwide that has
significant associated morbidity, mortality, and health care resource use. This study outlines the aetiology, clinical
presentation, and treatment outcomes of patients with UGIB in a Nigerian low resource health facility.
Methods: This was a descriptive study of consecutive patients who underwent upper gastrointestinal (GI)
endoscopy for upper GI bleeding in the endoscopy unit of the Obafemi Awolowo University Teaching Hospital
Complex, Ile-Ife, Osun State, Nigeria from January 2007 to December 2013.
Results: During the study period, 287 (12.4%) of 2,320 patients who underwent upper GI endoscopies had UGIB. Of
these, 206 (72.0%) patients were males and their ages ranged from 3 to 100 years with a median age of 49 years.
The main clinical presentation included passage of melaena stool in 268 (93.4%) of individuals, 173 (60.3%) had
haematemesis, 110 (38.3%) had haematochezia, and 161 (56.1%) were dizzy at presentation. Observed in 88 (30.6%)
of UGIB patients, duodenal ulcer was the most common cause, followed by varices [52 (18.1%)] and gastritis [51
(17.1%)]. For variceal bleeding, 15 (28.8%) and 21 (40.4%) of patients had injection sclerotherapy and variceal band
ligation, respectively. The overall rebleeding rate for endoscopic therapy for varices was 16.7%. For patients with
ulcers, only 42 of 55 who had Forrest grade Ia to IIb ulcers were offered endoscopic therapy. Endoscopic therapy
was áin 90.5% of the cases. No rebleeding followed endoscopic therapy for the ulcers. The obtained Rockall scores
ranged from 2 to 10 and the median was 5.0. Of all patients, 92.7% had medium or high risk scores. An increase in
Rockall score was significantly associated with length of hospital stay and mortality (p < 0.001). The overall mortality
rate was 5.9% (17 patients).
Conclusion: Endoscopic therapy for UGIB in a resource-poor setting such as Nigeria is feasible, significantly reduces
morbidity and mortality, and is cost effective. Efforts should be made to improve the accessibility of these therapeutic
procedure for patients with UGIB in Nigeria.
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Upper gastrointestinal bleeding (UGIB) is a major afflic-
tion that has been known from antiquity and remains a
common medical problem worldwide [1]. It is associated
with significant morbidity, mortality, and health care re-
source utilization [2]. It is estimated that about 100–150* Correspondence: segunalatishe@yahoo.co.uk
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unless otherwise stated.cases will occur per 100,000 adults per year in any given
population [3,4]. About 4–14% of the affected patients
will die from the condition, while 10–30% of patients
will have rebleeding [5-7]. In resource-poor settings
where facilities and the required equipment and training
that are necessary for the management of this condition
are limited, mortality will undoubtedly be higher.
Endoscopy has significantly revolutionised the manage-
ment of patients with UGIB. It is used for diagnosis, strati-
fying patients, and treating the disease [6]. TherapeuticLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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jection sclerotherapy and an endoscopic coagulation tech-
nique such as a heater probe, bipolar and monopolar
coagulation, and argon plasma coagulation have been used
to treat various causes of UGIB [6-8]. These treatment
modalities have been shown to reduce rebleeding, blood
transfusion requirements, and the need for ulcer surgery
for definitive haemostasis [8]. In addition, appropriate use
of endoscopy treatments significantly reduces hospital
length of stay and health care costs [9-11].
In Nigeria and many economically resource-poor coun-
tries, upper gastrointestinal (GI) endoscopy services are
not readily available. Where they are available, they are
seldom affordable for most patients. This has limited the
use of endoscopy in diagnosing the possible causes of
bleeding. Worse still, the paucity of trained manpower in
therapeutic procedures and the high cost of therapeutic
endoscopic accessories have further limited the use of
therapeutic techniques in the treatment of UGIB in
Nigeria. The few centres that introduced therapeutic tech-
niques had to adapt several modalities to reduce costs and
maintain supplies [12]. Since the introduction of upper GI
endoscopy to our hospital about three decades ago, few
therapeutic procedures were performed, as reported in the
literature [13]. Since 2007, different modalities of thera-
peutic procedures have been offered to patients that had
overt UGIB. This study outlines the aetiology of UGIB,
clinical presentation, treatment and outcomes of patients
treated with endoscopy for UGIB. We identify the possible
challenges preventing the routine use of these life-saving
techniques in Nigeria.
Methods
Study design and setting
This was a descriptive study of consecutive patients who
underwent upper GI endoscopy for UGIB in the endos-
copy unit of the Obafemi Awolowo University Teaching
Hospital Complex (OAUTHC), Ile-Ife, Osun State,
Nigeria from January 2007 and December 2013. The en-
doscopy unit is open electively on weekdays and for
emergencies on the weekend. OAUTHC is one of the
first-generation teaching hospitals in Nigeria and it pro-
vides tertiary level services that are mostly accessed by
patients from Osun, Ondo, Ekiti, and some parts of
Kwara, Kogi, Oyo, and Edo states with an estimated
population of about 10 million according to the 2006 na-
tional population census. The people of the Ife/Ijesa
zone of Osun, where the institution is located, are pre-
dominantly Yorubas, who along with other Nigerian
tribes reside permanently in this area. Peasant farming is
the major occupation of these people. A sizeable number
of people are engaged in commercial and small-scale in-
dustrial enterprises, whereas a significant number of the
educated population are civil servants.Study subjects
The study subjects included all patients who had overt
UGIB characterised by passage of melaena stool, haema-
temesis and/or haematochezia, whose sources of the
bleeding were identified from the oesophagus, stomach or
duodenum at upper gastrointestinal tract endoscopy and
who signed informed consent. When multiple sources
were identified, the principal cause of bleeding was ascer-
tained based on the clinical presentation and endoscopic
findings. All patients who had a bleeding episode from
other causes during hospitalisation were excluded from
the study. Ethical clearance was obtained before the com-
mencement of this study from the Obafemi Awolowo
University Teaching Hospitals Complex Ethics and Re-
search Committee.
Procedures
Most of the patients were admitted through the emer-
gency department of the hospital. Generally, patients
were resuscitated with intravenous fluids, blood and
blood products as indicated. A nasogastric tube was
inserted to monitor continuous bleeding. Endoscopy was
performed within 48 hours of admission especially when
there was evidence of continuous bleeding, features of
haemorrhagic shock at presentation and patients having
funds for the procedure. Those patients that were re-
ferred from other hospitals after resuscitation had the
procedure done at the next available endoscopy session.
Proton pump inhibitors were used routinely for patients
with suspected peptic ulcer bleeding at presentation
while beta blockers were administered routinely to pa-
tients with variceal bleeding once they were stabilised.
Somatostatin analogues and interventional radiology fa-
cilities were not available and were therefore not used in
any of the patients. The therapeutic methods used in-
cluded injection sclerotherapy, rubber band ligation,
heater probes and bipolar coagulation. Patients with
variceal bleeding received injection sclerotherapy or rub-
ber band ligation. The method of therapy offered was
also determined by what patients can afford. Patients
who had non-variceal bleeding, especially with gastric
and duodenal ulcers, received a combination of therapy
that included sclerotherapy and thermal therapy. Only
ulcer patients who had a Forrest Grade 1a to IIb ulcers
were routinely scheduled for endoscopic therapy. Agents
used for the injection therapy included adrenalin and/or
50% dextrose water. Patients with failed endoscopy ther-
apy were offered surgery.
Data collection
Data obtained included sociodemographic data, cause
of disease, clinical presentation, blood investigations in-
cluding complete blood count and clotting profile,
endoscopic findings, treatment modalities, and clinical
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pital stay, rebleeding rate, and mortality). Endoscopic
evaluation of the bleeding lesion in the case of peptic
ulcer was defined according to the Forrest classification
system as follows: FI (FIa and FIb), FII (FIIa, FIIb and
FIIc), and FIII [14]. Patients who had a variceal type of
upper GI bleeding were classified endoscopically ac-
cording to the severity of varices into four grades (i.e.,
grades I–IV) [15]. The grade assigned to each of the pa-
tients was based on the highest grade observed in each
patient. Gastric extension of the oesophageal varices
were classified using Sarin’s classification into GOV-1
or GOV-2, while isolated gastric varices were classified
as IGV-1 and IGV-2. Endoscopic diagnosis was consid-
ered to be accurate if stigmata of active or recent bleed-
ing were present, independently of the nature of the
bleeding lesion. Normal examination was defined by
the absence of any endoscopic abnormality. Shock was
defined as a systolic blood pressure below 90 mmHg at
presentation. Rebleeding was defined as a new bleeding
episode from the same source within 6 months after
the initial bleeding had stopped. The post-endoscopy
Rockall risk scoring system, which uses clinical (e.g.,
age, co-morbidity, and presence of shock) and endo-
scopic (e.g., diagnosis of stigmata of recent haemor-
rhage) criteria, was used to predict patients at risk for
developing adverse outcomes after acute UGIB [16].Figure 1 Age (years) distribution of patients with upper gastrointestiStatistical analyses
Data analysis was performed using the SPSS statistical
package for social sciences (SPSS, version 21.0; Chicago,
IL, USA) program. The mean ± standard deviation (SD),
median and ranges were calculated for continuous vari-
ables, whereas proportions and frequency tables were
used to summarise categorical variables. Continuous var-
iables were also categorised. A Chi-square (χ2) test was
used to test for the significance of association between
the independent (predictor) and dependent (outcome)
variables for categorical variables. Correlation analysis
was used to assess the relationship between Rockall
scores and the number of blood units transfused and du-
rations of hospital stay. The level of significance was
considered as P < 0.05.
Results
Demographic characteristics
During the study period, a total of 2,320 patients under-
went upper GI endoscopy, of which 287 (12.4%) had
UGIB. Two hundred and six (72.0%) patients were males
while 80 (28.0%) were females, with a male to female ra-
tio of 2.6:1. Patient ages ranged from 3 to 100 years with
a median age of 49 years. As shown in Figure 1, different
age groups were affected almost equally.
The patients had varying levels of education. Thirty-
nine (13.6%) patients had no formal education, 58 (20.2%)nal bleeding.
Alatise et al. BMC Gastroenterology 2014, 14:210 Page 4 of 9
http://www.biomedcentral.com/1471-230X/14/210had only a primary level education, 67 (23.4%) had a sec-
ondary level education and 123 (42.8%) had a tertiary level
education. The patients were from different walks of life.
Sixty-one (21.3%) of the patients were traders, 54 (18.8%)
were civil servants, 41 (14.3%) were students, 34 (11.9%)
were self-employed or artisans, 33 (11.5%) were retired, 28
(9.8%) were farmers, 20 (7.0%) were clergy, and 16 (5.6%)
were unemployed.
Clinical characteristics of patients
Passage of melaena stool was the most common [268
(93.4%)] presenting complaint. One hundred and seventy-
three (60.3%) and 110 (38.3%) patients presented with
haematemesis and haematochezia, respectively. Slightly
over half of the patients [161 (56.1%)] were dizzy at pres-
entation. Similarly, 152 (53.0%) presented with abdominal
pain, 27 (9.4%) presented with jaundice and 113 (39.4%)
had a history of recent ingestion of non-steroidal anti-
inflammatory drugs.
The use of alcohol or tobacco was reported in 35
(12.1%) and 8 (2.8%) patients, respectively. Previous his-
tory of dyspepsia was noted in 123 (42.9%) patients. Co-
morbidities included hypertension in 68 (23.7%), chronic
liver disease in 45 (15.7%), diabetic mellitus in 11 (3.8%),
previous cerebrovascular disease in 6 (0.7%) and renal
impairment in 4 (1.4%) patients. Eighty-nine (31.0%) pa-
tients presented with haemorrhagic shock.
Endoscopic diagnosis
As shown in Table 1, the sources of bleeding were
endoscopically identified in 265 (92.3%) patients. Duo-
denal ulcer [88 (30.6%)] was the most common cause of
UGIB, followed by varices [52 (18.1%)] and gastritis [51
(17.1%)]. Among patients with variceal bleeding, all hadTable 1 Spectrum of aetiological findings at upper GI
endoscopy in patients with upper gastrointestinal
bleeding
Endoscopic diagnosis Frequency Percentage
Duodenal Ulcer 88 30.6
Varices 52 18.1
Gastritis 51 17.1
Gastric ulcer 30 10.4
Normal finding 22 7.6
Gastric cancer 21 7.3
Reflux esophagitis 8 2.8
Gastrointestinal stroma tumour 8 2.8
Gastric polyp 4 1.4
Vascular bleeding 1 0.4
Mallory Weiss tear 1 0.4
Oesophageal cancer 1 0.4
Total 287 100.0oesophageal varices with gastric extension. According
to Sarin’s classification, GOV-1 was found in 41 (78.8%)
patients while GOV-2 was seen in 11 (21.2%) patients.
Four (7.8%) of these patients also had associated isolated
gastric varices. Of these, three were IGV-1 and one was
IGV-2. All patients had at least four oesophageal variceal
columns. No patient had grade I, seven (13.4%) patients
had grade II, thirty-seven (71.2%) patients had grade III,
and eight (15.4%) patients had grade IV.
According to Forrest classifications, the endoscopic
grade for gastric and duodenal ulcers were as follows;
Grade Ia: 3 (2.5%) patients, Grade Ib: 15 (12.7%), Grade
IIa: 16 (13.6%), Grade IIb: 21 (17.8%), Grade IIc: 36
(30.5%) and Grade III: 27 (22.9%).
Admission and treatment patterns
A total of 254 (88.5%) patients were admitted for the
management of upper GI bleeding either in our hospital
or the referring hospital. The treatments offered are
shown in Table 2. Of the 52 patients with variceal bleed-
ing, 15 (28.8%) had injection sclerotherapy to stop active
bleeding. Five (33.3%) patients had rebleeding from the
varices after injection therapy. Twenty one (40.4%) pa-
tients had variceal band ligation. Of these, 18 patients had
two sessions for variceal eradication. Rebleeding from the
varices occurred in one patient who had one session of
variceal ligation within 2 weeks of the procedure. Sixteen
(30.8%) patients who did not consent or could not af-
ford the cost of the therapeutic procedure were un-
treated. Twelve of the sixteen had recurrent bleeding
episodes and eventually died of the bleeding within one
year of follow up. The overall rebleeding rate in pa-
tients that had endoscopic therapy was 16.7% as com-
pared to 75.0% of patients who did not have any form
of endoscopic therapy, and this was a statistically sig-
nificant difference (p < 0.001).
For patients with ulcers, of the 55 patients who were
eligible for endoscopy therapy, only 42 patients could af-
ford endoscopic treatments. Endoscopic therapy was ef-
fective in 90.5% of the cases, while control of bleeding
could not be achieved in four (9.5%) patients. Of the 4
patients that died, 3 had surgical procedures and one
died before surgical intervention could be offered. One
patient who had surgical haemostasis rebled 2 months
after the procedure and died before arriving at theTable 2 Treatment pattern among patients with upper GI
bleeding
Treatment pattern Number of patients Percentage
Medical (conservative) treatment 186 64.8
Endoscopic treatment 82 28.6
Surgical treatment 19 6.6
Total 287 100
Table 4 Types of surgery performed in patients with
upper gastrointestinal bleeding
Type of surgery Frequency Percentage
Under-running of bleeding vessel 5 26.3
Gastrostomy 3 15.8
Subtotal gastrectomy 3 15.8
Partial gastrectomy 8 42.1
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had endoscopic haemostasis during the period of follow
up. Of the 13 patients who did not have any endoscopic
therapy, five (38.5%) had rebleeding necessitating re-
admission. All the five but two patients benefited from
endoscopic therapy, and surgical haemostasis was achieved
in the two patients who did not receive endoscopic ther-
apy. All patients with gastritis were treated with medical
therapy. No recurrence was recorded in any of these
patients.
Table 3 shows the indication for surgery in patients
that had UGIB in our study. Six patients who had endo-
scopic features of gastric cancer had active bleeding at
endoscopy. They had emergency surgery to control the
bleeding. Three patients each had surgical resection as
well as gastrotomy and haemostasis with electrocoagula-
tion. Surgical resections were also offered to patients
who had gastrointestinal stroma tumours (GIST). Endo-
scopic polypectomy was offered to patients who had
bleeding gastric polyps. Table 4 shows the procedures
performed in 19 patients that had surgical interventions.Rockall scoring system
The Rockall score was calculated for all patients. The
scores obtained ranged from 2 to 10 and the median
was 5.0. Of these, 21 (7.3%) patients had Rockall scores <3
(low risk group), 253 (88.2%) had scores of 3–8 (medium
risk group), and 13 (4.5%) had scores >8 (high risk group).
A higher Rockall score was significantly associated with
length of hospital stay and mortality (p < 0.001).Blood transfusion requirement
The median admission pack cell volume was 20.5% and
the range was 9–35%. Two-hundred-and-forty (83.6%)
patients had a blood transfusion during the course of
their treatment. The number of 500-ml units of blood
transfused ranged from 1 to 32. The median number of
transfusion units was three. The blood transfusion units
given were significantly different in patients who had en-
doscopy therapy compared to the non-endoscopy ther-
apy group in patients with variceal and duodenal
bleeding (p = 0.031 and p = 0.01, respectively; Table 5).
However, the transfusion requirements were not signifi-
cantly different in patients who survived versus thoseTable 3 Indications for surgery in patients with upper
gastrointestinal bleeding (n = 19)
Indication for surgery Frequency Percentage
Bleeding duodenal ulcers not responding
to either medical or endoscopic treatment
5 26.3
Gastric malignancy 6 31.6
Gastrointestinal stroma tumour 8 42.1who did not (p = 0.089), as well as in relation to Rockall
scores (p = 0.484).
Length of hospital stay
The overall length of hospital stay ranged from 1 to
20 days with a median of 4.5 days. Length of hospital
stay was significantly shorter in patients who received
endoscopy therapy for variceal and ulcer bleeding when
compared with those who did not receive therapy (p <
0.001; Table 5). The length of hospital stay was shorter
after endoscopic therapy when compared with those
who had surgical intervention (P < 0.001).
Mortality
The overall mortality rate was 5.9% (17 deaths). Of
these, 13 (67.4%) patients had variceal bleeding. Mortal-
ity was significantly higher in those patients who did not
have any form of endoscopic therapy compared with
those who were offered this therapy (p < 0.001; Table 5).
Two (11.8%) patients died following treatment for ulcers.
Two (11.8%) patients who had gastric resection for can-
cer died during the perioperative period.
Discussion
Upper gastrointestinal bleeding continues to be a sig-
nificant cause of morbidity and mortality worldwide,
which places a significant demand on healthcare facil-
ities [2-4,17]. In our experience, it is one of the leading
causes of referral for upper GI endoscopy. We found
that 12.6% of the endoscopy referrals were for UGIB.
This is higher than previously reported from our centre,
[18] but similar to findings reported by Malu et al. [19]
in their series from Northern Nigeria. However,
Olokooba et al. [20] reported a high rate in the middle
belt of Nigeria. This disparity may be due to the fact
that the latter was an initial report with a small sample
size. Being an initial report, the referrals were likely
those that would benefit from the upper GI endoscopy
the most.
Upper GI endoscopy remains the most effective mo-
dality to localise the site and cause of bleeding in over
95% of patients, especially when the procedure is per-
formed within 24 hours of bleeding [5,21,22]. In the
present study, the site of bleeding was detected in 91.6%
of patients, which was similar to findings previously
Table 5 Mortality, rebleeding, blood transfusion requirement, and length of hospital stay for endoscopic and non-
endoscopic therapy
Endoscopic therapy Non endoscopic therapy p
Varices 36 16
Mortality in six months 2 8 <0.001
Rebleeding 5 12 <0.001
Blood transfusion units Mean ± SD 3.0 ± 3.6 4.7 ± 5.7 0.031
Hospital stay (in days) Mean ± SD 5.0 ± 1.6 9.2 ± 5.4 <0.001
Duodenal ulcer 42 13
Rebleeding 0 5 <0.001
Blood transfusion units Mean ± SD 2.8 ± 3.4 3.1 ± 3.1 0.01
Hospital stay (in days) Mean ± SD 3.7 ± 2.0 9.4 ± 4.9 <0.001
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cedure done within 48 hours of the initial occurrence of
bleeding. Mucosal lesions are well known to heal quickly
and generally the time interval between the bleeding epi-
sode and the endoscopic procedure is known to influ-
ence the accuracy and likelihood of finding a cause
endoscopically [25]. Therefore, the availability of emer-
gency endoscopy within 24 hours is most desirable. In
reality, however, emergency endoscopy is rarely available
in most healthcare centres in developing countries due
to the insufficiency of well-trained endoscopists, trained
support staff, or equipment. In addition, difficulty in
accessing tertiary health services due to the poor referral
systems that characterise most developing countries also
prevents early presentation and detection of the cause of
bleeding.
Our finding that duodenal ulcers were the most com-
mon cause of upper gastrointestinal bleeding in our
study is consistent with reports from most Western
countries [26-28]. Most studies from the Western world
report that almost half of their cases with UGIB are due
to duodenal ulcers, which is higher than the finding in
this study [26-30]. The possible reason may be because
of the fact that the median age of our patients was
almost a decade lower than the average age in most
Western case series [28,29]. It is worth noting that vari-
ceal bleeding was the most common cause of UGIB in
Northern Nigeria and most parts of North Africa where
there is a high prevalence of chronic liver disease due to
hepatitis B infection and schistosomiasis [19,22,25,31-33].
This implies that the most common cause of UGIB in any
given environment may be influenced by the prevalence of
hepatitis B virus and schistosomiasis. However, we found
that oesophageal varices were the second-most common
cause of UGIB in our cohort. All of the patients in our
study had a history of liver disease from hepatitis B or C
virus. None of the patients had screening or preventive
therapy for cirrhosis. In fact the diagnosis of cirrhosis washeralded by the occurrence of variceal bleeding in some of
these patients. This implies that public education must be
undertaken to inform people of the early features of liver
disease and the advantages of early diagnosis.
Furthermore, in our study, gastritis accounted for the
third-most common cause of UGIB. It should be noted
that Ajayi et al. reported that gastritis was the most
common cause of UGIB in their case study from south-
west Nigeria [34]. Most of our patients were either farmers,
artisans or traders. This group of patients is known to
work long hours and they often abuse over-the-counter
analgesics including nonsteroidal anti-inflammatory drugs
(NSAIDs). Hence, gastritis and peptic ulcer-related causes
were a common cause of UGIB in our series. This propos-
ition is supported by the fact that almost 40% of our pa-
tients gave a history of recent or chronic use of NSAIDs.
This finding was similar to a previous report from Nigeria
[20]. However, the percentage is low compared to another
study from Africa [22]. Data from Spain indicated that
more than 50,000 gastrointestinal bleeding events and
more than 1,000 deaths yearly were attributable to aspirin
or other NSAID use [35,36]. This national statistic trans-
lates to an NSAID-associated mortality of 5.6% or 15.3
deaths per 100,000 users [36]. Mortality from NSAIDs
has, however, been reduced significantly because of a de-
crease in the prevalence of Helicobacter pylori infection as
a result of frequent use of over-the-counter antibiotics.
Additionally, increased use of proton pump inhibitors,
widespread efforts to use lower doses of NSAIDs, in-
creased use of safer NSAIDs, and improved treatment of
acute ulcer bleeding have also contributed to lower mor-
tality rates [37-40]. However, in Nigeria where there is a
high prevalence of H. pylori [41] and indiscriminate use
and purchase of NSAIDs across the counter, the morbidity
and mortality of NSAID use may actually be on the rise.
Regulations to discourage the prescription and dispensing
of drugs by unqualified personnel are of paramount im-
portant in reducing this negative trend.
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80% of patients with UGIB will experience an end of
bleeding especially after treatment with medical therapy
[30]. In this index study, however, only about two-thirds
of the patients needed no other form of therapy than
medical therapy. This may be because most of the cases
of UGIB in our cohort were severe. This assertion was
substantiated by the fact that over a third of the patients
presented with haemorrhagic shock. Similarly, over 80%
of our patients had a Rockall score of either medium or
high risk. It may also be that only severe cases were re-
ferred to the tertiary health facility for treatment, while
the mild cases were treated at the peripheral centre. In
addition, health care expenses are largely out-of-pocket,
so this may screen out mild cases.
This study also identify that endoscopic therapy was
very effective for patients who could afford it. It also sig-
nificantly reduced hospital stays and the number of pa-
tients that needed surgical haemostasis. Despite fewer
endoscopic options due to availability, the effectiveness
of endoscopic therapy in ulcer bleeding was comparable
to a previous report [42]. This study reinforces the need
to improve the availability and accessibility of endo-
scopic therapy for patients with UGIB. This can be
achieved through collaboration with world bodies such
as the World Gastroenterology Organization. Involve-
ment of non-governmental organisations in sponsoring
training programs and treatment of patients with UGIB
are also needed.
This study also confirmed a previous report that vari-
ceal eradication using endoscopic rubber band ligation
may be more effective than injection sclerotherapy [43].
Most patients with variceal bleeding needed more than
one session for eradication because of a higher grade of
varices encountered in the study. Patients should be
properly counselled on the need for repeated procedures
with variceal eradication at the commencement of ther-
apy to improve compliance.
Rebleeding rates in this study were very low following
endoscopic therapy and were expectedly higher in pa-
tients who did not have endoscopic haemostasis. This
difference was most pronounced in patients with vari-
ceal bleeding. Rebleeding is associated with increased
mortality; therefore, timely identification and aggressive
management of patients at high risk for continued
bleeding or rebleeding have become a major focus of
UGIB therapy [43].
The mortality in this study was comparable to what
was reported in previous studies [26,44,45]. Most of the
mortality in this study was from variceal bleeding, espe-
cially in patients who did not have endoscopic therapy.
The preventable deaths of patients with cirrhosis could
be avoided if treatment is made free of charge for this
group of patients.One of the challenges encountered in management of
patients with UGIB in developing countries is availability
of safe blood for transfusion. Blood banks are always
undersupplied, meaning that patients may have to pro-
vide donors when blood is needed. Only patients with
good support are able to receive enough blood during
resuscitation. In fact, most of the cases of mortality arise
because of a lack of donor blood. While patients with
higher Rockall scores needed more blood, survival is de-
termined by the ability to stop bleeding endoscopically
or surgically.
Despite the relevance of this study to a low resource
setting, we noted some inherent defects in the study.
Treatments were guided by availability and affordability
rather than guidelines. This reflects the current situation
of most resource-poor settings. Similarly, the H. pylori
status of the patients was determined only by histopath-
ology of biopsy specimens rather than medical records,
which were not available for analysis. This limited the
interpretation of the results of H. pylori status may also
influence rebleeding rates.Conclusion
In conclusion, this study clearly showed that UGIB is a
common problem among Nigerians. Endoscopic therapy
in a resource-poor setting like Nigeria is feasible, signifi-
cantly reduces morbidity and mortality and is a cost-
effective treatment. Efforts should be made to improve the
accessibility of therapeutic procedures for patients with
UGIB in Nigeria and other low resource settings.
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